GIORGIANA RAMIREZ: Open Payments
NPI 1831828821 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,629 in 237 payments from 36 companies in 2025. Trend: 2023 $0 · 2024 $2,888 · 2025 $4,629
Food & beverage: $4,629
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 31 | $864 |
| TG Therapeutics, Inc. | 22 | $526 |
| Novartis Pharmaceuticals Corporation | 20 | $333 |
| ABBVIE INC. | 27 | $257 |
| UCB, Inc. | 15 | $228 |
| Teva Pharmaceuticals USA, Inc. | 18 | $226 |
| Neurocrine BioSciences, Inc. | 5 | $215 |
| Axsome Therapeutics, Inc. | 12 | $172 |
| Eisai Inc. | 5 | $162 |
| PFIZER INC. | 12 | $145 |
Products named: NUPLAZID, BRIUMVI, Leqembi, KESIMPTA, AUSTEDO XR, INGREZZA, Rystiggo, QULIPTA.
Industry payments across SC — which companies pay providers there.
